Harrow (HROW) Short-term Investments (2013 - 2024)
Harrow's (HROW) quarterly Short-term Investments came in at $7.4 million in Q1 2024, down 2.59% year-on-year from $7.6 million in Q2 2023, and down 14.38% quarter-over-quarter from $8.7 million in Q4 2023.
Harrow (HROW) Short-term Investments (2013 - 2024) Analysis & Trends
Harrow's Short-term Investments history runs 10 years deep, the most recent figure standing at $7.4 million for Q1 2024.
- On a quarterly basis, Short-term Investments fell 2.59% year-over-year to $7.4 million in Q1 2024; TTM through Mar 2024 was $7.4 million, a 2.59% decrease from a year earlier, with the FY2023 full-year figure at $8.7 million, up 55.32% from the prior year.
- Short-term Investments retreated to $7.4 million in Q1 2024 per HROW's latest filing, from $8.7 million in the prior quarter.
- Across five years, Short-term Investments topped out at $28.5 million in Q4 2020 and bottomed at $4.2 million in Q3 2022.
- The 5-year median for Short-term Investments is $8.3 million (2023), against an average of $9.4 million.
- Across the five-year window, Short-term Investments plunged 70.12% in 2021 and surged 98.58% in 2023, its largest moves.
- Year by year, Short-term Investments stood at $28.5 million in 2020, then plunged by 70.12% to $8.5 million in 2021, then slumped by 34.27% to $5.6 million in 2022, then soared by 55.32% to $8.7 million in 2023, then fell by 14.38% to $7.4 million in 2024.
- Per Business Quant, the three latest HROW Short-term Investments figures stand at $7.4 million (Q1 2024), $8.7 million (Q4 2023), and $8.3 million (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 7.43 Mn |
| Dec 31, 2023 | 8.68 Mn |
| Sep 30, 2023 | 8.27 Mn |
| Jun 30, 2023 | 6.92 Mn |
| Mar 31, 2023 | 7.63 Mn |
| Dec 31, 2022 | 5.59 Mn |
| Sep 30, 2022 | 4.16 Mn |
| Jun 30, 2022 | 5.19 Mn |
| Mar 31, 2022 | 8.64 Mn |
| Dec 31, 2021 | 8.50 Mn |
| Sep 30, 2021 | 9.99 Mn |
| Jun 30, 2021 | 12.21 Mn |
| Dec 31, 2020 | 28.46 Mn |
| Dec 31, 2017 | 200,000.00 |
| Sep 30, 2017 | 200,000.00 |
| Jun 30, 2017 | 200,000.00 |
| Mar 31, 2017 | 200,000.00 |
| Dec 31, 2016 | 200,000.00 |
| Sep 30, 2016 | 450,000.00 |
| Jun 30, 2016 | 150,000.00 |